Scinai Immunotherapeutics
0
18
+€0.00+0% 00:00 Today
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Financials
-633.91%Profit Margin
Unprofitable1.11MRevenue
-7.06MNet Income
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units: (i) Scinai R&D, focused on the development of therapeutics in inflammation and immunology, and (ii) the contract development and manufacturing organization (CDMO) business. The CDMO business provides integrated development and manufacturing services to small and emerging biotech companies, supporting clients from early-stage development through clinical-stage production.
Show more...
CEO
Employees
45
Country
Israel
ISIN
US09073Q4029
WKN
000A42JHP
Listings
0 Comments
Share your thoughts
FAQ
What is Scinai Immunotherapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange Scinai Immunotherapeutics stocks are traded under the ticker 2F50.MU.
What is Scinai Immunotherapeutics revenue for the last year?▼
Scinai Immunotherapeutics revenue for the last year amounts to 1.11M EUR.
What is Scinai Immunotherapeutics net income for the last year?▼
2F50.MU net income for the last year is -7.06M EUR.
How many employees does Scinai Immunotherapeutics have?▼
As of September 03, 2026, the company has 45 employees.
In which sector is Scinai Immunotherapeutics located?▼
Scinai Immunotherapeutics operates in the Other sector.
When did Scinai Immunotherapeutics complete a stock split?▼
The last stock split for Scinai Immunotherapeutics was on August 21, 2026 with a ratio of 1:10.
Where is Scinai Immunotherapeutics headquartered?▼
Scinai Immunotherapeutics is headquartered in JERUSALEM, Israel.